Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rachael Fleurence"'
Publikováno v:
BMJ Surgery, Interventions, & Health Technologies, Vol 2, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/e301732e3a944f2396aa996670723316
Autor:
Christi Lane-Barlow, Isabel Thomas, Libby Horter, Rachael Fleurence, Jamilla Green, Krishna Juluru, Ramona Byrkit, Andrew Weitz, Jessica N. Ricaldi, Diana Valencia
Publikováno v:
Journal of Public Health Management and Practice. 29:539-546
Autor:
Sarah E Daugherty, Sarita Wahba, Rachael Fleurence, Paul Avillach, Janice Buelow, Richard Colletti, Florian Eichler, Seth Ginsberg, Esi Morgan Dewitt, Robert McBurney, Peter A. Merkel, Richard Mularski, Marc Natter, Andrew A. Nierenberg, Liz Horn, Megan O'Boyle, Holly Peay, Mark Pletcher, Susan Redline, Bruce Robinson, Michael D Kappleman, Kathleen E. Sullivan, Sue Friedman, Rebecca Sutphen, John Walsh
Publikováno v:
Journal of the American Medical Informatics Association : JAMIA
The Patient-Centered Outcomes Research Institute (PCORI) recently launched PCORnet to establish a single inter-operable multicenter data research network that will support observational research and randomized clinical trials. This paper provides an
Autor:
Rachael, Fleurence, Rebecca, Williamson, Yonghua, Jing, Edward, Kim, Quynh-Van, Tran, Andrei S, Pikalov, Michael E, Thase
Publikováno v:
Psychopharmacology bulletin. 42(3)
Major depressive disorder (MDD) is a leading cause of disability worldwide. Clinicians need to determine the most appropriate and effective interventions for patients who do not benefit from first-line treatment. A systematic review of the literature
Autor:
Rachael, Fleurence, Eldon, Spackman
Publikováno v:
The Journal of rheumatology. 33(11)
Four new biologic treatments have been approved for several autoimmune disorders. Economic evaluations have been used to model their cost-effectiveness.We conducted a structured literature review in Embase and PubMed to identify all relevant cost-eff